{"id":"https://openalex.org/W4403296328","doi":"https://doi.org/10.1158/1078-0432.27205457","title":"Supplementary Data from A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors","display_name":"Supplementary Data from A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors","publication_year":2024,"publication_date":"2024-10-10","ids":{"openalex":"https://openalex.org/W4403296328","doi":"https://doi.org/10.1158/1078-0432.27205457"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.27205457","doi":"https://doi.org/10.1158/1078-0432.27205457","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.27205457","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.27205457","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065435809","display_name":"James J. Harding","orcid":"https://orcid.org/0000-0002-7029-4310","observed_orcids":["https://orcid.org/0000-0002-7029-4310","https://orcid.org/0000-0003-0766-9965"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James J. Harding","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7029-4310","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052487618","display_name":"Melinda L. Telli","orcid":"https://orcid.org/0000-0001-7993-1235","observed_orcids":["https://orcid.org/0000-0001-7993-1235"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melinda Telli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083373965","display_name":"Pamela N. M\u00fcnster","orcid":"https://orcid.org/0000-0002-2074-0984","observed_orcids":["https://orcid.org/0000-0002-2074-0984","https://orcid.org/0009-0009-4141-2312"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pamela Munster","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091859782","display_name":"Martin Henner Voss","orcid":"https://orcid.org/0000-0003-0551-5807","observed_orcids":["https://orcid.org/0000-0003-0551-5807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin H. Voss","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0551-5807","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103514741","display_name":"Jeffrey R. Infante","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey R. Infante","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005537242","display_name":"Angela M. DeMichele","orcid":"https://orcid.org/0000-0003-1297-4251","observed_orcids":["https://orcid.org/0000-0003-1297-4251"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela DeMichele","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018829094","display_name":"Mark P. Dunphy","orcid":"https://orcid.org/0000-0002-1886-1832","observed_orcids":["https://orcid.org/0000-0002-1886-1832"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Dunphy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048372431","display_name":"Mai Hope Le","orcid":"https://orcid.org/0000-0001-5246-6097","observed_orcids":["https://orcid.org/0000-0001-5246-6097"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mai H. Le","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084995152","display_name":"Chris Molineaux","orcid":"https://orcid.org/0000-0001-7737-0593","observed_orcids":["https://orcid.org/0000-0001-7737-0593"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris Molineaux","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7737-0593","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109262452","display_name":"Keith William Orford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keith Orford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011277647","display_name":"Frank Parlati","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank Parlati","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013695327","display_name":"Sam H. Whiting","orcid":"https://orcid.org/0009-0000-8736-0583","observed_orcids":["https://orcid.org/0009-0000-8736-0583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sam H. Whiting","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055304416","display_name":"Mark K. Bennett","orcid":"https://orcid.org/0000-0003-1046-1292","observed_orcids":["https://orcid.org/0000-0003-1046-1292"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark K. Bennett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058115259","display_name":"Nizar M. Tannir","orcid":"https://orcid.org/0000-0001-5559-8060","observed_orcids":["https://orcid.org/0000-0001-5559-8060"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nizar M. Tannir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5076426660","display_name":"Funda Meric\u2010Bernstam","orcid":"https://orcid.org/0000-0001-6816-6072","observed_orcids":["https://orcid.org/0000-0001-6816-6072"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Funda Meric-Bernstam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.2736999988555908,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.2736999988555908,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.26460000872612,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.03849999979138374,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/telaglenastat","display_name":"telaglenastat","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4659999907016754},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7369999885559082},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.765999972820282},{"id":"https://openalex.org/keywords/hsp90-inhibitors","display_name":"Hsp90 inhibitors","score":0.38100001215934753}],"concepts":[{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.5401387214660645},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.4500489830970764},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42876729369163513},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42166972160339355},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3607841432094574},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3588123917579651},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.18859556317329407},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.16412556171417236},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.27205457","doi":"https://doi.org/10.1158/1078-0432.27205457","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.27205457","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/27205457","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Data_from_A_Phase_I_Dose-Escalation_and_Expansion_Study_of_Telaglenastat_in_Patients_with_Advanced_or_Metastatic_Solid_Tumors/27205457","pdf_url":"https://figshare.com/articles/journal_contribution/Supplementary_Data_from_A_Phase_I_Dose-Escalation_and_Expansion_Study_of_Telaglenastat_in_Patients_with_Advanced_or_Metastatic_Solid_Tumors/27205457","source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.27205457","doi":"https://doi.org/10.1158/1078-0432.27205457","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.27205457","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403296328.pdf","grobid_xml":"https://content.openalex.org/works/W4403296328.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3185688873","https://openalex.org/W4403319199","https://openalex.org/W4362491677","https://openalex.org/W4362487746","https://openalex.org/W4362487723","https://openalex.org/W2914951474","https://openalex.org/W2947461064","https://openalex.org/W4362491689","https://openalex.org/W4386224891","https://openalex.org/W3009518972"],"abstract_inverted_index":{"Figures":[0],"S1-S3":[1],"and":[2],"Supplementary":[3],"Methods":[4]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-10-11T00:00:00"}